vimarsana.com

Latest Breaking News On - Small molecule drugs - Page 3 : vimarsana.com

FDA approves Arcutis skin foam for seborrheic dermatitis

The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve for the skin condition seborrheic dermatitis in people aged nine years and up.

Anagenex and Nimbus join forces to develop small molecule treatments using AI

The drug discovery specialist Anagenex has sealed a collaboration pact with Nimbus Therapeutics to co-develop small molecule drugs with the help of artificial intelligence (AI).

vimarsana © 2020. All Rights Reserved.